Mesenchymal Stem Cell Therapy Prevents Interstitial Fibrosis and Tubular Atrophy in a Rat Kidney Allograft Model

In solid organ transplantation, mesenchymal stem cell (MSC) therapy is strongly emerging among other cell therapies due to the positive results obtained in vitro and in vivo as an immunomodulatory agent and their potential regenerative role. We aimed at testing whether a single dose of MSCs, injecte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Franquesa, Marcella, Herrero, Esther, Torras, Joan, Ripoll, Elia, Flaquer, Maria, Gomà, Montse, Lloberas, Nuria, Anegon, Ignacio, Cruzado, Josep M., Grinyó, Josep M., Herrero-Fresneda, Immaculada
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2012
Matèries:
Original Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3495114/
https://ncbi.nlm.nih.gov/pubmed/22494435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/scd.2012.0096
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars